Medical Professionals
Publications

Publications: Our research

Filter

Filter

Clear filter
Research Area
Technology
Resource type
Category
138 results found
Feb 2, 2024
Publication
Novavax led
Journal of Virology
COVID-19, Matrix-M™ adjuvant
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Traci L. Bricker , Astha Joshi , Nadia Soudani, et al.
View
Jan 30, 2024
Publication
Collaborative
The Journal of Clinical Investigation
Malaria, Matrix-M™ adjuvant
A randomized first-in-human Phase 1 trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
B. Alfred Tiono, Jordan Plieskatt, Alphonse Ouedraogo, et al.
View
Jan 24, 2024
Publication
Novavax led
Vaccine
COVID-19, Matrix-M™ adjuvant
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study
Matthew Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
View
Jan 24, 2024
Publication
Novavax led
Vaccine
COVID-19, Matrix-M™ adjuvant
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States
Kyle Paret, Hadi Beyhaghi, William L. Herring, et al.
View
Jan 18, 2024
Publication
Novavax led
Preprint
COVID-19, Matrix-M™ adjuvant
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, et al.
View
Nov 22, 2023
Publication
Novavax led
The Journal of Infectious Diseases
COVID-19, Matrix-M™ adjuvant
The Novavax Heterologous COVID Booster Demonstrates Lower Reactogenicity Than mRNA: A Targeted Review
Anthony M. Marchese, Matthew Rousculp, John Macbeth, et al.
View
Nov 16, 2023
Publication
Novavax led
The Journal of Infectious Diseases
COVID-19, Matrix-M™ adjuvant
Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-cov-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial
Chijioke Bennett, E Joy Rivers, Wayne Woo, et al.
View
Nov 7, 2023
Publication
Novavax led
Frontiers in Drug Delivery
COVID-19, Matrix-M™ adjuvant
Biodistribution of the Saponin-Based Adjuvant Matrix-M™ Following Intramuscular Injection in Mice
Cecilia Carnrot, Berit Carow, Anna-Karin E. Palm, et al.
View
Nov 6, 2023
Publication
Novavax led
Scientific Reports
COVID-19, Matrix-M™ adjuvant
XBB.1.5 spike protein COVID‑19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants
Nita Patel, Jessica F. Trost, Mimi Guebre‑Xabier, et al.
View
Sep 20, 2023
Publication
Novavax included/third party
eBioMedicine
COVID-19, Matrix-M™ adjuvant
Risk of COVID-19 after natural infection or vaccination
Anne-Marie Rick, Matthew B. Laurens, Ying Huang, et al.
View